Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences

Overview of attention for article published in Journal of Translational Medicine, December 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 84 Dimensions

Readers on

mendeley: 52 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

COMBINATORIAL CANCER IMMUNOTHERAPY

Application EP-4022067-A4

European Patent Office

METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING UROTHELIAL CANCER

Application WO-2016203476-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.